Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Oxford Handbook of Oncology -

Oxford Handbook of Oncology

Buch | Teilwerk (Buch)
896 Seiten
2015 | 4th Revised edition
Oxford University Press (Verlag)
978-0-19-968984-2 (ISBN)
CHF 63,95 inkl. MwSt
This practical guide to clinical consultation in oncology has been extensively revised and updated. It reflects recent advances in oncology with particular emphasis on new therapies and the emergence of immunotherapy as a real modality.
Now fully revised and in its fourth edition, the Oxford Handbook of Oncology has been the essential go-to guide for students and practitioners in oncology for over a decade. The scientific basis and diagnosis of cancers is covered, as well as drugs, biomarkers, and the presentation and psychosocial aspects of oncology. Concise, practical, and comprehensive, there is no better companion for both common conditions and challenging emergencies.

The field of oncology has surged forward since the last edition was published and the Oxford Handbook of Oncology has been fully revised and updated to reflect these recent advances so you can be sure that the vital information you need is in your hands. This handbook incorporates changes such as the understanding of the science of cancer, novel therapies in breast, lung, renal, and melanoma, molecular sub-classification of common solid cancers, personalized therapy approaches, new agents in hard to treat cancers, the benefits of new technologies in radiotherapy, and the emerging data on the importance of the immune response.

Written by experts in the field to ensure that it is grounded in real life clinical practice, this handbook provides a concise guide to all aspects of oncology for all students, nurses, and junior faculty responsible for the care of cancer patients, while also providing further reading and highlighting areas of controversy for those who need a more detailed understanding.

Jim Cassidy was previously Professor of Oncology at Aberdeen university (1994-2002), then CRUK Head of Oncology, Beatson Laboratories, Glasgow. He moved into pharma over 2 years ago to head early drug development. Donald Bissett was schooled in Glasgow, and graduated from St Andrews University 1979 and University of Manchester 1982. Clinical experience in South Manchester Hospitals led to MRCP 1986, then commenced clinical oncology training in Nottingham and Glasgow, with FRCR 1989. Research Fellowship in the Department of Medical Oncology Beatson Institute, with MD and MSc in Clinical Pharmacology 1992. Senior lecturer in Clinical Oncology 1994, then Consultant in Clinical Oncology in Aberdeen 1995-2013 with particular interests in urological and thoracic malignancies.

1. Multidisciplinary approach to cancer ; 2. Aetiology and epidemiology ; 3. Genetics of cancer ; 4. Surgical oncology ; 5. Principles of radiation oncology ; 6. Principles of chemotherapy ; 7. Principles of symptom control in palliative care ; 8. Late effects of radiotherapy and chemotherapy ; 9. Hormone therapy ; 10. Biological and targeted therapies ; 11. Clinical trials ; 12. Cancer prevention ; 13. Population screening for cancer ; 14. Thoracic cancer ; 15. Breast cancer ; 16. Colorectal cancer ; 17. Anal cancer ; 18. Upper gastrointestinal cancer ; 19. Endocrine cancers ; 20. Genitourinary cancers ; 21. Gynaecological cancer ; 22. Head and neck cancer ; 23. Tumours of the central nervous system ; 24. Skin cancer ; 25. Haematological malignancies ; 26. Bone and soft tissue malignancies ; 27. Cancer of unknown primary site ; 28. Paraneoplastic syndromes ; 29. AIDS-related malignancies ; 30. Childhood cancers presenting in adulthood ; 31. Overview of Acute Oncology ; 32. Spinal cord compression and bone marrow suppression ; 33. Superior vena cava obstruction and raised intracranial pressure ; 34. Stridor ; 35. Thromboembolic and cardiac emergencies ; 36. Obstruction ; 37. Biochemical crises ; 38. Complications of long-term central venous lines and chemotherapy extravasation ; 39. Novel therapeutic strategies ; 40. Gene therapy and immunotherapy for cancer ; 41. Biomarkers and Cancer ; Appendices

Reihe/Serie Oxford Medical Handbooks
Zusatzinfo 25 black and white line illustrations and 6 colour plates
Verlagsort Oxford
Sprache englisch
Maße 105 x 184 mm
Gewicht 541 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Chirurgie
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Medizinische Fachgebiete Palliativmedizin
Medizin / Pharmazie Pflege Palliativpflege / Sterbebegleitung
ISBN-10 0-19-968984-9 / 0199689849
ISBN-13 978-0-19-968984-2 / 9780199689842
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich